Novus Therapeutics Completes Enrollment of Phase 2a Trial of OP0201 in Pediatric Patients with Acute Otitis Media
NOVUS THERAPEUTICS (NVUS)
US:NASDAQ Investor Relations:
ir.novustherapeutics.com/news-releases
Company Research
Source: Business Wire
IRVINE, Calif.--(BUSINESS WIRE)--Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat, today announced that it has completed enrollment of the phase 2a trial of OP0201 in pediatric patients with acute otitis media (study C-006). The company enrolled a total of 103 patients into the clinical trial and expects to report data by early June 2020.“Completion of enrollment for this first OP0201 efficacy clinical trial marks a major milestone for our company,” said Dr. Catherine Turkel, President of Novus Therapeutics. “We look forward to sharing the results of study C-006 in the coming months. Millions of children are affected by otitis media every year and OP0201 could someday play an important role in the treatment of this condition,” concluded Dr. Turkel.The clinical trial is designed to detect a 25% difference between treatment groups in at least one of the two primary effi
Show less
Read more
Impact Snapshot
Event Time:
NVUS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVUS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVUS alerts
High impacting NOVUS THERAPEUTICS news events
Weekly update
A roundup of the hottest topics